veerta sharma

Employment

• Chitkara college of Pharmacy Assistant Professor

Education

• Chitkara College of Pharmacy Ph.D

Projects & Funding

Projects & funding information is unavailable.

Publications (33)

• Pharmacological evaluation of Orai-1 inhibitor in 3-nitropropionic acid-induced Huntington disease
  Journal of Pharmacy and Pharmacology 2026 DOI: 10.1093/jpp/rgag030
  +Save
• Programmed cell death pathways in Huntington’s disease: spotlight on ferroptosis and pyroptosis
  Neurological Sciences 2026 DOI: 10.1007/s10072-025-08689-4
  +Save
• Cardiotoxicity Induced by Targeted Cancer Therapies: Understanding the Risks and Developing Solutions
  Cardiovascular Drugs and Therapy 2026 DOI: 10.1007/s10557-025-07790-2
  +Save
• Mechanistic insights on the role of Nrf-2 signalling in Huntington’s disease
  Neurological Sciences 2025 DOI: 10.1007/s10072-024-07802-3
  +Save
• Neuroanatomical mapping of spexin and nesfatin-1-expressing neurons in the human brainstem
  Neuropeptides 2025 DOI: 10.1016/j.npep.2024.102484
  +Save
• Modulating lipid droplet dynamics in neurodegeneration: an emerging area of molecular pharmacology
  Molecular Biology Reports 2025 DOI: 10.1007/s11033-025-10381-x
  +Save
• Intersecting molecular pathways in Synucleinopathies and Amyloidogenesis: Exploring shared mechanisms and therapeutic potential
  Brain Research 2025 DOI: 10.1016/j.brainres.2025.149568
  +Save
• Diabetic Cardiomyopathy: An Update on Emerging Pathological Mechanisms
  Current Cardiology Reviews 2025 DOI: 10.2174/011573403X331870241025094307
  +Save
• Cerebral ischemia-reperfusion induces the expression of phoenixin receptor (GPR173) and adult neurogenesis marker proteins in the rat striatum
  Brain Injury 2025 DOI: 10.1080/02699052.2024.2443004
  +Save
• Ferroptosis and Alzheimer’s: unveiling new avenues for the treatment and prevention
  Metabolic Brain Disease 2025 DOI: 10.1007/s11011-025-01587-w
  +Save